Trial intelligence / Profile preview

Testosterone in heart failure

NCT01469988Phase 2Terminated

Sponsor
University of Alberta
Start
Nov 2012
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Testosterone TEPI patch in heart failure (HF), sponsored by University of Alberta. Started Nov 2012; status: terminated.

02

Drugs

Testosterone TEPI patch
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01469988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01469988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call